Real-time imaging of beta-catenin dynamics in cells and living mice.

Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron (2014) 2.83

Advances in bioluminescence imaging of live animal models. Curr Opin Biotechnol (2009) 1.55

Lats2 kinase potentiates Snail1 activity by promoting nuclear retention upon phosphorylation. EMBO J (2011) 1.26

Dual-color click beetle luciferase heteroprotein fragment complementation assays. Chem Biol (2010) 1.16

Kinetics of Wnt-driven beta-catenin stabilization revealed by quantitative and temporal imaging. PLoS One (2008) 1.00

A novel luciferase fusion protein for highly sensitive optical imaging: from single-cell analysis to in vivo whole-body bioluminescence imaging. Anal Bioanal Chem (2014) 0.87

A dual-color luciferase assay system reveals circadian resetting of cultured fibroblasts by co-cultured adrenal glands. PLoS One (2012) 0.85

Quantitatively controlling expression of miR-17~92 determines colon tumor progression in a mouse tumor model. Am J Pathol (2014) 0.83

Construction and Experimental Validation of a Petri Net Model of Wnt/β-Catenin Signaling. PLoS One (2016) 0.82

A biochemical screen for identification of small-molecule regulators of the Wnt pathway using Xenopus egg extracts. J Biomol Screen (2011) 0.82

Silencing of IkBβ mRNA causes disruption of mitochondrial retrograde signaling and suppression of tumor growth in vivo. Carcinogenesis (2012) 0.81

Spectral unmixing imaging of wavelength-responsive fluorescent probes: an application for the real-time report of amyloid Beta species in Alzheimer's disease. Mol Imaging Biol (2012) 0.80

How can grafted breast cancer models be optimized? Cancer Biol Ther (2011) 0.78

Wnt/beta-catenin signaling in development and disease. Cell (2006) 30.09

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science (1997) 22.80

A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A (1996) 11.37

Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther (1999) 8.28

Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta (2003) 7.85

Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J Biol Chem (1997) 4.28

Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals. Proc Natl Acad Sci U S A (2004) 3.59

beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene (2006) 3.43

Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res (2006) 3.17

A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol (2002) 3.09

Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouse. Mol Cell Biol (1998) 3.09

Pygopus and Legless target Armadillo/beta-catenin to the nucleus to enable its transcriptional co-activator function. Nat Cell Biol (2004) 2.90

Spatial expression of the Drosophila segment polarity gene armadillo is posttranscriptionally regulated by wingless. Cell (1990) 2.33

Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death. J Neurochem (2001) 2.32

Real-time imaging of ligand-induced IKK activation in intact cells and in living mice. Nat Methods (2005) 2.22

Imaging 26S proteasome activity and inhibition in living mice. Nat Med (2003) 2.04

Casein kinase 2 associates with and phosphorylates dishevelled. EMBO J (1997) 1.97

Proteasome inhibitors cause induction of heat shock proteins and trehalose, which together confer thermotolerance in Saccharomyces cerevisiae. Mol Cell Biol (1998) 1.57

Endogenous protein kinase CK2 participates in Wnt signaling in mammary epithelial cells. J Biol Chem (2000) 1.46

Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1. J Biol Chem (2006) 1.28

Inhibition of beta-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H(2)O(2) at physiologically relevant EGCG concentrations. Biochem Biophys Res Commun (2002) 1.27

Proteasome inhibitor PS-341, a potential therapeutic agent for adult T-cell leukemia. Cancer Res (2002) 1.25

beta-Catenin signaling: therapeutic strategies in oncology. Cancer Biol Ther (2003) 1.21

Spectral unmixing of multicolored bioluminescence emitted from heterogeneous biological sources. Anal Chem (2006) 1.16

In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein. Clin Cancer Res (2005) 1.10

Impact of quercetin and EGCG on key elements of the Wnt pathway in human colon carcinoma cells. J Agric Food Chem (2006) 1.02

Lysosomal trafficking of beta-catenin induced by the tea polyphenol epigallocatechin-3-gallate. Mutat Res (2005) 0.92

High-content screening assay for activators of the Wnt/Fzd pathway in primary human cells. Assay Drug Dev Technol (2005) 0.82

A cellular assay for measuring the inhibition of glycogen synthase kinase-3 via the accumulation of beta-catenin in Chinese hamster ovary clone K1 cells. Assay Drug Dev Technol (2006) 0.78

Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature (2012) 8.03

CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res (2004) 4.53

Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100. Blood (2008) 3.77

Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals. Proc Natl Acad Sci U S A (2004) 3.59

Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J Cell Biol (2009) 3.50

P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest (2005) 2.81

Spying on cancer: molecular imaging in vivo with genetically encoded reporters. Cancer Cell (2005) 2.74

Bioluminescence imaging of myeloperoxidase activity in vivo. Nat Med (2009) 2.43

Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice. J Virol (2002) 2.31

Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. Cancer Res (2012) 2.24

Real-time imaging of ligand-induced IKK activation in intact cells and in living mice. Nat Methods (2005) 2.22

Imaging 26S proteasome activity and inhibition in living mice. Nat Med (2003) 2.04

Cerenkov radiation energy transfer (CRET) imaging: a novel method for optical imaging of PET isotopes in biological systems. PLoS One (2010) 2.02

The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis. Nat Cell Biol (2013) 1.93

Optical imaging of bacterial infection in living mice using a fluorescent near-infrared molecular probe. J Am Chem Soc (2006) 1.93

Noninvasive imaging of protein-protein interactions in living animals. Proc Natl Acad Sci U S A (2002) 1.81

Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression. Clin Cancer Res (2008) 1.75

Imaging reversal of multidrug resistance in living mice with bioluminescence: MDR1 P-glycoprotein transports coelenterazine. Proc Natl Acad Sci U S A (2004) 1.56

Advances in bioluminescence imaging of live animal models. Curr Opin Biotechnol (2009) 1.55

Recent advances in imaging the lungs of intact small animals. Am J Respir Cell Mol Biol (2004) 1.51

Current state of imaging protein-protein interactions in vivo with genetically encoded reporters. Annu Rev Biomed Eng (2007) 1.50

Squaraine rotaxanes: superior substitutes for Cy-5 in molecular probes for near-infrared fluorescence cell imaging. Angew Chem Int Ed Engl (2007) 1.47

LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy. Proc Natl Acad Sci U S A (2010) 1.47

The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling. J Clin Invest (2012) 1.45

Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo. Cancer Res (2007) 1.44

Breast cancer cell targeting by prenylation inhibitors elucidated in living animals with a bioluminescence reporter. Clin Cancer Res (2012) 1.41

TAT-BH4 and TAT-Bcl-xL peptides protect against sepsis-induced lymphocyte apoptosis in vivo. J Immunol (2006) 1.41

Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity. Blood (2009) 1.40

Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model. Proc Natl Acad Sci U S A (2009) 1.40

Senescent stromal-derived osteopontin promotes preneoplastic cell growth. Cancer Res (2009) 1.38

Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner. Blood (2006) 1.35

Noninvasive optical imaging of staphylococcus aureus bacterial infection in living mice using a Bis-dipicolylamine-Zinc(II) affinity group conjugated to a near-infrared fluorophore. Bioconjug Chem (2008) 1.34

An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging. Bioconjug Chem (2009) 1.34

Contribution of p53 to metastasis. Cancer Discov (2014) 1.28

Mechanics of EGF receptor/ErbB2 kinase activation revealed by luciferase fragment complementation imaging. Proc Natl Acad Sci U S A (2011) 1.27

Biochemical and in vivo characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. Biochemistry (2007) 1.27

Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice. Exp Hematol (2007) 1.25

Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivo. Proc Natl Acad Sci U S A (2007) 1.25

Quantitation of selective autophagic protein aggregate degradation in vitro and in vivo using luciferase reporters. Autophagy (2009) 1.25

Linkage between cellular communications, energy utilization, and proliferation in metastatic neuroendocrine cancers. Proc Natl Acad Sci U S A (2006) 1.23

Molecular imaging of gene expression and protein function in vivo with PET and SPECT. J Magn Reson Imaging (2002) 1.21

Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1. Cancer Res (2010) 1.20

APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice. J Cell Biochem (2008) 1.18

Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression. Cancer Res (2012) 1.17

Characterization of coelenterazine analogs for measurements of Renilla luciferase activity in live cells and living animals. Mol Imaging (2004) 1.16

Spectral unmixing of multicolored bioluminescence emitted from heterogeneous biological sources. Anal Chem (2006) 1.16

Dual-color click beetle luciferase heteroprotein fragment complementation assays. Chem Biol (2010) 1.16

Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment. Cancer Res (2011) 1.15

CD47 regulates bone mass and tumor metastasis to bone. Cancer Res (2009) 1.14

Luciferase fragment complementation imaging of conformational changes in the epidermal growth factor receptor. J Biol Chem (2009) 1.12

Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases. Clin Cancer Res (2009) 1.12

Quantitative analysis of permeation peptide complexes labeled with Technetium-99m: chiral and sequence-specific effects on net cell uptake. Bioconjug Chem (2003) 1.12

Synthesis and characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. J Med Chem (2005) 1.11

In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein. Clin Cancer Res (2005) 1.10

Characterization of novel histidine-tagged Tat-peptide complexes dual-labeled with (99m)Tc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopy. Bioconjug Chem (2002) 1.10

IFNγR signaling mediates alloreactive T-cell trafficking and GVHD. Blood (2012) 1.09

Rational design of novel red-shifted BRET pairs: Platforms for real-time single-chain protease biosensors. Biotechnol Prog (2009) 1.06

Real-time imaging of notch activation with a luciferase complementation-based reporter. Sci Signal (2011) 1.05

Selective cell uptake of modified Tat peptide-fluorophore conjugates in rat retina in ex vivo and in vivo models. Invest Ophthalmol Vis Sci (2006) 1.04

Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation. Cancer Discov (2012) 1.04

Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells. Stem Cells (2007) 1.04

Generation of a highly inducible Gal4-->Fluc universal reporter mouse for in vivo bioluminescence imaging. Proc Natl Acad Sci U S A (2008) 1.04

Visualizing protein-protein interactions in living animals. Methods (2003) 1.03

Permeation peptide conjugates for in vivo molecular imaging applications. Mol Imaging (2006) 1.03

Optimizing luciferase protein fragment complementation for bioluminescent imaging of protein-protein interactions in live cells and animals. Methods Enzymol (2004) 1.02

Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-kappaB and MAPK signaling pathways. FASEB J (2010) 1.01

Interleukin 12 stimulates IFN-gamma-mediated inhibition of tumor-induced regulatory T-cell proliferation and enhances tumor clearance. Cancer Res (2009) 1.01

Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone. Proc Natl Acad Sci U S A (2007) 1.01

Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier. J Nucl Med (2005) 1.01

CD8+ T cells regulate bone tumor burden independent of osteoclast resorption. Cancer Res (2011) 1.00

Dissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunit. FASEB J (2009) 1.00

The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts. Bone (2009) 0.99

Human cord blood progenitors with high aldehyde dehydrogenase activity improve vascular density in a model of acute myocardial infarction. J Transl Med (2010) 0.99

Molecular imaging strategies for drug discovery and development. Curr Opin Chem Biol (2006) 0.99

Monitoring proteasome activity in cellulo and in living animals by bioluminescent imaging: technical considerations for design and use of genetically encoded reporters. Methods Enzymol (2005) 0.99

Continuous delivery of D-luciferin by implanted micro-osmotic pumps enables true real-time bioluminescence imaging of luciferase activity in vivo. Mol Imaging (2007) 0.98

Vascular Endothelial Growth Factor Receptor-1 Is Synthetic Lethal to Aberrant {beta}-Catenin Activation in Colon Cancer. Clin Cancer Res (2009) 0.98

Kinetics of in vivo elimination of suicide gene-expressing T cells affects engraftment, graft-versus-host disease, and graft-versus-leukemia after allogeneic bone marrow transplantation. J Immunol (2004) 0.98

Fine-tuning p53 activity through C-terminal modification significantly contributes to HSC homeostasis and mouse radiosensitivity. Genes Dev (2011) 0.98

TAT-Bim induces extensive apoptosis in cancer cells. Ann Surg Oncol (2007) 0.97

Evidence for a plasma membrane-mediated permeability barrier to Tat basic domain in well-differentiated epithelial cells: lack of correlation with heparan sulfate. Biochemistry (2002) 0.97

In vivo optical imaging of acute cell death using a near-infrared fluorescent zinc-dipicolylamine probe. Mol Pharm (2011) 0.95

Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors. Blood (2008) 0.95

Measuring brain tumor growth: combined bioluminescence imaging-magnetic resonance imaging strategy. Mol Imaging (2009) 0.94

Caspase-activated cell-penetrating peptides reveal temporal coupling between endosomal release and apoptosis in an RGC-5 cell model. Bioconjug Chem (2012) 0.94

Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesis. Mol Cell Biol (2010) 0.93

T-cell activation promotes tumorigenesis in inflammation-associated cancer. Retrovirology (2009) 0.93

Characterization of a novel 99mTc-carbonyl complex as a functional probe of MDR1 P-glycoprotein transport activity. Mol Imaging (2003) 0.93

Bioluminescence imaging of period1 gene expression in utero. Mol Imaging (2007) 0.93

The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice. PLoS One (2010) 0.93

Second-generation triple reporter for bioluminescence, micro-positron emission tomography, and fluorescence imaging. Mol Imaging (2006) 0.92

Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth. Mol Cancer Res (2011) 0.92

Knocking down nucleolin expression in gliomas inhibits tumor growth and induces cell cycle arrest. J Neurooncol (2012) 0.90

Forkhead box O1 (FOXO1) protein, but not p53, contributes to robust induction of p21 expression in fasted mice. J Biol Chem (2013) 0.89

Identification of a ligand-induced transient refractory period in nuclear factor-kappaB signaling. J Biol Chem (2008) 0.89

Structure-activity relationships, kinetics, selectivity, and mechanistic studies of synthetic hydraphile channels in bacterial and mammalian cells. Org Biomol Chem (2005) 0.89

18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas. J Nucl Med (2013) 0.89

Illuminating cancer systems with genetically engineered mouse models and coupled luciferase reporters in vivo. Cancer Discov (2013) 0.89

Stably integrated luxCDABE for assessment of Salmonella invasion kinetics. Mol Imaging (2009) 0.88

F11R is a novel monocyte prognostic biomarker for malignant glioma. PLoS One (2013) 0.87